Teneligliptin clinical trials
Also written MP-513.
How each study uses teneligliptin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
27 studies that test it; most in 2009 (4)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 25 · Other 2
Handok Inc. (13) · Tanabe Pharma Corporation (12) · Yonsei University (1) · National Cerebral and Cardiovascular Center, Japan (1)
Often tested with
Tested in the same studies.
Sulfonylurea Antidiabetic Agent (1) · N,N''-sulfonylbis-urea (1) · Insulin (1) · Empagliflozin (1) · Atorvastatin (1) · Metformin (1)
Related medicines
As reviewed, each with the page that says it.
- One of DPP-4 inhibitors source
Studies
Open first, then newest update. How each study uses teneligliptin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 27
- Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)CompletedPhase 3Tanabe Pharma CorporationNCT02354222Written as TeneligliptinHow we know
- Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 DiabetesCompletedPhase 2Tanabe Pharma CorporationNCT00971243Written as MP-513 Lowest Dose and MetforminHow we know
- Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 DiabetesCompletedPhase 3Tanabe Pharma CorporationNCT02220907Written as Teneligliptin/CanagliflozinHow we know
- Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes MellitusCompletedPhase 3Tanabe Pharma CorporationNCT02916706Written as Teneligliptin 20mgHow we know
- Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes MellitusCompletedPhase 3Tanabe Pharma CorporationNCT02924064Written as Teneligliptin 20mgHow we know
- Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 DiabetesCompletedPhase 3Tanabe Pharma CorporationNCT00974090Written as Placebo / Teneli (Teneligliptin) + SU (Sulfonylurea)How we know
- Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic PatientsCompletedPhase 3Tanabe Pharma CorporationNCT02314637Written as TeneligliptinHow we know
- Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes MellitusCompletedPhase 3Tanabe Pharma CorporationNCT01072331Written as MP-513How we know
- Monotherapy Study of MP-513 in Patients With Type 2 DiabetesCompletedPhase 3Tanabe Pharma CorporationNCT00998881Written as Teneligliptin 20 mgHow we know
- Efficacy and Safety Study of MP-513 in Patients With Type 2 DiabetesCompletedPhase 2Tanabe Pharma CorporationNCT00628212Written as Teneligliptin 10mgHow we know
- Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 DiabetesCompletedPhase 4Tanabe Pharma CorporationNCT02081599Written as Teneli (Teneligliptin)How we know
- Long-term Safety Study of MP-513 in Patients With Type 2 DiabetesCompletedPhase 3Tanabe Pharma CorporationNCT01301833Written as teneligliptinHow we know
- Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and MetforminCompletedPhase 3Handok Inc.NCT05504226Written as Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral TabletHow we know
- Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)CompletedPhase 4Handok Inc.NCT02512523Written as TeneligliptinHow we know
- Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and MetforminCompletedPhase 3Handok Inc.NCT05504239Written as Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral TabletHow we know
- Tenelia Elderly CGMS Study(TEDDY)CompletedPhase 4Handok Inc.NCT03508323Written as TeneligliptinHow we know
- Pharmacokinetic Drug Interaction Between Teneligliptin and EmpagliflozinCompletedPhase 1Handok Inc.NCT04431141Written as TeneligliptinHow we know
- A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic RegimenCompletedPhase 4Yonsei UniversityNCT04446026Written as teneligliptinHow we know
- Teneligliptin and Atorvastatin DDI StudyCompletedPhase 1Handok Inc.NCT03769870Written as Teneligliptin 20mg/dayHow we know
- Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two PatientsCompletedPhase 4Handok Inc.NCT03011177Written as TeneligliptinHow we know
See all 27 studies that test teneligliptin →
Given beside what is tested · 1 — teneligliptin is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with teneligliptin
- Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy VolunteersCompletedPhase 1Handok Inc.NCT07102719Written as Teneligliptin and EmpagliflozinHow we know
- Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy VolunteersCompletedPhase 1Handok Inc.NCT06889350Written as TeneligliptinHow we know
- Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy VolunteersCompletedPhase 1Handok Inc.NCT06339788Written as TeneligliptinHow we know
Codes
What other systems call teneligliptin · ClinicalTrials.gg INT006250
- UNII (FDA) 28ZHI4CF9CTENELIGLIPTINConfirmed FDA, Wikidata
- Wikidata Q15269678teneligliptinConfirmed FDA, Wikidata
- NCI Thesaurus C87623TeneligliptinOne source FDA
- DrugBank DB11950One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 28ZHI4CF9C | TENELIGLIPTIN | Confirmed FDA, Wikidata |
| Wikidata | Q15269678 | teneligliptin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C87623 | Teneligliptin | One source FDA |
| DrugBank | DB11950 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.